1.Effects of the dosing regimen of tissue-type plasminogen activator on blood coagulation system in experimental pulmonary embolism.
Hee Soon CHUNG ; Ho Joong KIM ; Young Soo SHIM
Tuberculosis and Respiratory Diseases 1993;40(5):474-482
No abstract available.
Blood Coagulation*
;
Pulmonary Embolism*
;
Tissue Plasminogen Activator*
2.DNA Sequencing of p53 Gene Mutation in Colorectal Carcinomas.
Young Ran SHIM ; Joon Hyuk CHOI ; Won Hee CHOI
Korean Journal of Pathology 1999;33(6):422-433
Mutations in the p53 gene occur during the development of colorectal carcinomas, and play an important role in the conversion of adenoma into carcinoma. To detect the p53 gene mutation and its pattern of expression in colorectal carcinomas, polymerase chain reaction for exons 5, 6, 7, and 8, recombinant gene cloning, and automated DNA sequencing were performed with 30 fresh colorectal carcinomas. Each tissue was also analyzed by immunohistochemical staining for p53 protein. p53 protein was detected in 25 of 30 (83.3%) colorectal carcinomas by immunohistochemical study. p53 mutation was detected in 4 of 30 (13.3%) colorectal carcinomas. The distribution of these mutations among these exons investigated was as follows: Three mutations in exon 5 (66.7%) and 1 mutation in exon 7 (33.3%). One case with mutation in exon 5 had mutations at three different codons. Mutations in exon 5 were found at codon 153 (GGG to AGG: Gly to Arg), 170 (TGC to GGC: Cys to Gly), 186 (CTA to TTA: silent mutation), 158 (GCG to ACG: Ala to Thr), and 176 (ACG to ATG: Thr to Met). Mutation in exon 7 was found at codon 248 (AGG to AGA: silent mutation). Four of them were missense mutations. Two of 6 mutations were silent mutations. Five transition mutations and 1 transversion mutation were also detected. All cases with mutations by automated DNA sequencing showed positive p53 protein immunohistochemical stainining. In conclusion, p53 gene mutation was detected in 4 of 30 (13.3%) colorectal carcinomas, located in codon 153, 158, 170, 176, and 186 of exon 5 and codon 248 of exon 7. Further studies are needed to evaluate the significance of the codon 153 mutation which was not recognized in other studies on colorectal carcinomas.
Adenoma
;
Clone Cells
;
Cloning, Organism
;
Codon
;
Colorectal Neoplasms*
;
DNA*
;
Exons
;
Genes, p53*
;
Mutation, Missense
;
Polymerase Chain Reaction
;
Sequence Analysis, DNA*
3.Expression of Oncogene Product in the Colorectal Carcinoma.
Young Ran SHIM ; Woo Young JANG ; Kyoung Chan CHOI ; Joon Hyuk CHOI ; Won Hee CHOI ; Min Chul SHIM
Yeungnam University Journal of Medicine 1995;12(2):210-225
The expression of p62"' and p2l can be seen in many solid tumor, but the pattern and incidence of expression were different according to organ, countries, and examiners, thus it is not definitely defined. Total 67 colorectal carcinoma in paraffin sections are analysed by immunohistochemically for evaluation of the p62and p21- expression according to the age, sex, chief complaints, location, differentiation, modified Dukes stage, using the specific monoclonal antibodies. The results were summarized as follows : The age of patients ranged from 32 years to 82 years. The mean age was 57.6 years. The expression of p 62y' and p21 was not correlated with age. Male was 29 cases(43.3%) and female was 38 cases(56.7%). The male to female ratio was 1:1.31. The and 95.0% in moderately differentiated adenocarcinoma, 90.0% and 90.0% in poorly differentiated <,;, adenocarcmoma, 100.0% and 100.0% in mucinous carcinoma. The positive rate of p62!and and p2l' was 94.1% and 88.2% in Dukes stage B,, 96.0% and 96.0% in Dukes stage B,, 100.0% and 100.0% in Dukes stage C,, 100.0% and 88.9% in Dukes stage C, and 100.0% and 100. o% in Dukes stage D. The expression of p62 y' in metastatic colorectal carcinoma showed diffuse and strongly positive reaction than primary colorectal carcinoma. The expression of p21 in primary colorectal carcinoma showed diffuse and strongly positive reaction than metastatic colorectal carcinoma.
Adenocarcinoma
;
Adenocarcinoma, Mucinous
;
Antibodies, Monoclonal
;
Colorectal Neoplasms*
;
Female
;
Humans
;
Immunohistochemistry
;
Incidence
;
Male
;
Oncogene Proteins*
;
Oncogenes*
;
Paraffin
4.A Case of Complete Resolution of Aortic Dissection in the Descending Thoracic Aorta Treated with Endovascular Stent-Graft Implantation.
Dae Keun SHIM ; Hee Doo KYUNG ; Young Sup YOON ; Byung Chul CHANG ; Do Yun LEE ; Won Heum SHIM
Korean Circulation Journal 2000;30(12):1583-1588
The aortic dissection is an acute aortic syndrome, caused by an intimal tear and subsequent splitting of the media by the pulsatile blood flow. Though there would be differences in the origin of aortic dissection and therapeutic modalities, the intermediate and long-term prognoses are poor. Endovascular Stent-graft implantation is a revolutionary technique in the treatment of aortic dissection. The endovascular stent grafting in aortic dissection is less invasive and feasible method and is an effective tool for closing the entry site and promoting clot formation, reducing the size of the false lumen. Therefore, endovascular Stent-graft implantation makes possible the desirable remodelling of aorta. We report 33 year-old male with aortic dissection in the thoracic aorta, which was treated with endovascular Stent-graft implantation. Over the favorable remodelling, his dissection was healed completely by the endovascular treatment using Stent-graft.
Adult
;
Aorta
;
Aorta, Thoracic*
;
Blood Vessel Prosthesis
;
Humans
;
Male
;
Prognosis
5.The effects of acute exercise on plasma concentration of follicular stimulating hormoen(FSH), estradiol, progesterone in women.
Si Young JUNG ; Hee Kyung CHOI ; Young Soo JIN ; Jae Sik SHIM ; Chang Jae LYU
Korean Journal of Obstetrics and Gynecology 1993;36(7):2843-2856
No abstract available.
Estradiol*
;
Female
;
Humans
;
Plasma*
;
Progesterone*
6.Supplement of Incomplete Apoptosis Through CD8/Fas Chimeric Molecule by PMA of IFN-gamma.
Sang Kyou LEE ; Jae Hyuck SHIM ; Jung Hee LIM ; Jae Young LEE ; Young Sub SONG
Korean Journal of Immunology 1998;20(2):203-209
No abstract available.
7.A Pediatric Case of Korean Hemorrhagic Fever Confirmed by Fluorescent Antibody Technique.
Young Ill PARK ; Joon Hee OH ; Sang Woo KIM ; Jin Young CHOI ; Tae Sub SHIM
Journal of the Korean Pediatric Society 1978;21(10):685-
A case of Korean hemorrhagic fevery confirmed by fluorescent antibody technique in a 8years old boy was reported with a brief review of references.
Fluorescent Antibody Technique*
;
Hemorrhagic Fever with Renal Syndrome*
;
Humans
;
Male
8.Gastric Carcinoma with Lymphoid Stroma: Pathologic and immunohistochemical study of 14 cases.
Eun Hee LEE ; Woo Young JANG ; Kyoung Chan CHOI ; Young Ran SHIM ; Joon Hyuk CHOI ; Won Hee CHOI
Korean Journal of Pathology 1996;30(2):115-120
A total of 672 surgically resected gastric carcinomas were reviewed, and fourteen cases(2.1%) of "gastric carcinoma with lymphoid stroma" were identified. The tumor was located mostly in cardia and body portion(86%). Thirteen patients one was lost to follow up were alive without recurrence of tumor. Grossly, this carcinoma was characterized by an expanding growth pattern or a multinodular pattern. Histologically, this carcinoma showed an irregular trabecular and alveolar arrangement and densely infiltrated lymphoid cells with lymph follicles. The tumor cell nests were widely separated by non-desmoplastic lymphoid stroma. On immunohistochemical study, T cells were evenly distributed throughout the tumor lesion with intimate contact with individual carcinoma cells, but B cells were mainly present within the germinal centers of lymph follicles. Thus, the organized immune response combined with cell mediated and humoral immunities against the carcinoma cells may be a defense mechanism of the host in this type of gastric carcinoma.
9.The Clinical Value of the Serum and Urinary Levels of beta-HCG in Transitional Cell Carcinoma of the Bladder.
Sang Ik LEE ; Tae Hee OH ; Hi Young SHIM
Korean Journal of Urology 1996;37(6):646-651
It has been reported that beta-HCG is produced in the transitional cell carcinoma of the bladder and measuring of its level can be used as a tumor marker. We measured the serum and urinary levels of beta-HCG in the patients with the transitional cell carcinoma of the bladder and analysed the relationship to the clinical stage and histological grade and its significance as a tumor marker. The levels of the beta-HCG in the serum and early morning urine were measured in 40 cases of transitional cell carcinoma of the bladder and 37 cases of control group. Double-antibody immunometric assay (Coat-A-Count HCG IRMA) using I-labeled anti HCG antibody and monoclonal anti HCG antibody were used. The mean levels of the serum and urinary f-HCG in control group were 1.2mIU/ml, 1.4mIU/ ml and 3.6mIU/ml, 6.0mIU/ml in patient group, which showed a statistically significant difference between the two groups(p<0.05). In patient group, the levels of the serum and urinary beta- HCG were 2.9mIU/ml and 3.5mIU/ml in the superficial tumor, 2.6mIU/ml and 7.0mIU/ml in the invasive tumor and 7.5mIU/ml and 9.9mIU/ml in the metastatic tumor, showing a statistically significant increase as the clinical stage was advanced(p <0.05). The levels of the serum and urinary beta-HCG were 3.3mIU/ml and 1.3mIU/ml in grade I, 2.9mIU/ml and 5.9mIU/ml in grade II and 4.7mIU/ml and 7.6mIU/ml in grade III, which did not demonstrate a significant relationship to the histological grade(p>0.05). We think that the serum and urinary levels of beta-HCG in the transitional cell carcinoma of the bladder are related to the tumor stage but not to the histological grade and in the metastatic tumor urinary beta-HCG level can be used as a reliable tumor marker.
Carcinoma, Transitional Cell*
;
Humans
;
Urinary Bladder*
10.Argyrophilic Nucleolar Organizer Region and Expression of Ki-67 in Malignant Lymphoma.
Hee Jung LEE ; An Hi LEE ; Kyo Young LEE ; Chang Suk KANG ; Sang In SHIM ; Byung Kee KIM
Korean Journal of Pathology 2000;34(4):257-263
Nucleolar organizer regions (NORs) are loops of DNA which occur in the nucleoli of cells which possess ribosomal RNA genes. The numbers and areas of NORs have been thought to be related to cellular activities. We aimed to investigate the direct relationship between the parameters of AgNORs and cellular proliferative activity using immunohistochemical method with the monoclonal antibody Ki-67, which demonstrates proliferating nuclei. The sequential technique for the simultaneous Ki-67 immunostaining and NOR staining was applied to the same slides of a series of non-Hodgkin's lymphomas (NHL) of the low, intermediate, and high grade type. The number of AgNOR per cell was counted and mean NOR percentage nuclear area (NPNA) was measured by morphometry in both the Ki-67 positive and Ki-67 negative nuclei. The increased immunoreactivity for Ki-67 was found in the high grade than in the low grade non-Hodgkin's lymphoma. This was reflected in the two areas of the palatine tonsils and lymph nodes, the positive cell counts being higher in the follicle center nuclei than in those in the interfollicular compartment. In general the numbers and NPNA of AgNORs were higher in the Ki-67 positive nuclei than in those lacking the antigen in malignant lymphomas as well as in control. The AgNORs numbers and NPNA in controls were the highest in the Ki-67 positive cells in the follicular area and the lowest in the Ki-67 negative cells in the perifollicular area. In malignant lymphomas the numbers and NPNA of AgNORs tended to increase in proportion to their grade in both the Ki-67 positive and negative cells. The numbers of AgNORs of the high grade and the NPNA of the intermediate and the high grade were significantly higher in Ki-67 positive cells than in Ki-67 negative ones. With this double staining method it was now possible to confirm that numbers and NPNA of AgNORs were directly related to the cellular proliferative activity. In maligant lymphoma, among the several parameters of the AgNORs, NPNA in Ki-67 positive cells is proposed to be the most useful marker in determining the prognosis of the patient.
Cell Count
;
DNA
;
Genes, rRNA
;
Humans
;
Lymph Nodes
;
Lymphoma*
;
Lymphoma, Non-Hodgkin
;
Nucleolus Organizer Region*
;
Palatine Tonsil
;
Prognosis